1Zhou L,Jiang W,Ren C,et.al.Frequent hypermethylation of RASSF1A and TSLC1,and high viral load of Epstein-Barr Virus DNA in nasopharyngeal carcinoma and matched tumor-adjacent tissues[J].Neoplasia,2005,7(9):809.
2Lo KW,Kwong J,Hui AB,et al.High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma[J].Cancer Res,2001,61(10):3877.
3Sekido Y,Ahmadian M,Wistuba D,et al.Cloning of a breast cancer homozygous deletion junction narrows the region of search for a 3p21.3 tumor suppressor gene[J].Oncogene,1998,16(24):3151.
4Dammann R,Li C,Yoon JH,et al.Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3[J].Nat Genet,2000,25(3):315.
5Burbee DG,Forgacs E,Zochbauer Muller S,et al.Epigenetic inactivation of RASSF1A in lung and breast cancer and malignant phenotype suppression[J].J Natl Cancer Inst,2001,93(9):691.
6Hogg RP,Honorio S,Martinez A,et al.Frequent 3p allele liss and epigenetic inactivation of the RASSF1Atumor suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma[J].Eur J Cancer,2002,38(12):1585.
7Vos MD,Ellis CA,Bell A,et al.Ras uses the novel tumor suppressor RASSF1 as an effector to mediate apoptosis[J].J Biol Chem,2000,275(46):35669.
8Westphal CH,Schmaltz C,Rowan S,et al.Genetic interactions between atm and p53 influence cellular proliferation and irradiation induced cell cycle checkpoints[J].Cancer Res,1997,57(9):1664.
3Cheng Y, Poulos NE, Lung ML, et al. Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3 [J ]. Proc Nail Acad Sci USA, 1998, 95(6): 3042-7.
4Lerman MI, Minna JD. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium [ J ]. Cancer Res, 2000, 60(21): 6116-33.
5Dammann R, Li C,Yoon JH,Chin PL,et al.Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 [J ]. Nat Genet, 2000, 25(3): 315-9.
6Burbee DG, Forgacs E, Zochbauer-Muller S, et al. Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression[J]. J Natl Cancer Inst, 2001, 93(9): 691-9.
7Baylin SB, Herman JG. Promoter hypermethylation-can this change alone ever designate true tumor suppressor gene function [ J ]? J Natl Cancer Inst, 2001, 93(9): 664-5.
8Lehmann U, Langer F, Feist H, et al. Quantitative assessment of promoter hypermethylation during breast cancer development[ J ]. Am J Pathol, 2002, 160(2): 605-12.
9Morrissey C, Martinez A, Zatyka M, et al. Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene in both clear cell and papillary renal cell carcinoma[ J ]. Cancer Res, 2001, 61(19): 7277-81.
10Lo KW, Kwong J, Hui AB, et al. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma[J]. Cancer Res, 2001, 61(10): 3877-81.
